Detalhe da pesquisa
1.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 205(2): 267-279, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453781
2.
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
Cancer
; 129(7): 1085-1095, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642837
3.
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
Oncologist
; 28(10): e867-e876, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589218
4.
Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study.
Br J Cancer
; 127(5): 886-891, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715631
5.
Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial.
BMC Cancer
; 22(1): 493, 2022 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35509030
6.
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors.
Reprod Biomed Online
; 44(6): 1031-1044, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525718
7.
Uptake of Recommendations for Posttreatment Cancer-Related Fatigue Among Breast Cancer Survivors.
J Natl Compr Canc Netw
; 20(13)2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130491
8.
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET).
Angiogenesis
; 23(2): 193-202, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31773439
9.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Lancet
; 393(10191): 2591-2598, 2019 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31178155
10.
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
Br J Cancer
; 121(12): 991-1000, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719684
11.
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Breast Cancer Res
; 19(1): 98, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28830573
12.
A Case of Generalized Interstitial Granuloma Annulare and Arthritis Associated with Breast Cancer.
Acta Derm Venereol
; 99(2): 244-245, 2019 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30281136
13.
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Lancet Oncol
; 14(8): 741-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23764181
14.
Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer
; 202: 114037, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554542
15.
Change in the value of work after breast cancer: evidence from a prospective cohort.
J Cancer Surviv
; 17(3): 694-705, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267143
16.
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
Clin Breast Cancer
; 23(7): e412-e419, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423801
17.
Sustainable return to work among breast cancer survivors.
Cancer Med
; 12(18): 19091-19101, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602836
18.
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort.
Eur J Cancer
; 189: 112935, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385070
19.
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
J Natl Cancer Inst
; 115(9): 1099-1108, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434306
20.
Contraceptive Use in Premenopausal Women With Early Breast Cancer.
JAMA Netw Open
; 5(9): e2233137, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36149651